BeOne Medicines (NasdaqGS:BGNE) Q3 2025 Earnings Call November 06, 2025 08:00 AM ET Company ParticipantsDan Maller - Head of Investor RelationsAaron Rosenberg - CFOXiaobin Wu - President and COOMatt Shaulis - General Manager of North AmericaClara Dong - VP of Biotechnology Equity ResearchJohn Oyler - CEOSean Laaman - Executive Director and Lead US SMID Cap Biotechnology Equity ResearchMark Lanasa - Chief Medical Officer of Solid TumorsYigal Nochomovitz - Director of Biotech Equity ResearchLai Wang - Global ...